C. Agostini (Padova, Italy), J. Grutters (Nieuwegein, The Netherlands)
Presence of Cox2 polymorphisms and susceptibility to sarcoidosis and its evolution
D. Rodriguez Rodriguez, J. L. Lopez-Campos Bodineau, I. Alfageme Michavila, J. Fernandez de Cordoba Gamero, A. Romero Ortiz, A. Montes Worboys, E. Arellano Orden, E. Rodriguez Becerra (Sevilla, Marbella, Granada, Spain)
|  |
DR and DQ alleles distribution: comparison sarcoidosis with tuberculosis
A. Dubaniewicz, M. Dubaniewicz-Wybieralska, G. Moszkowska, A. Sternau, A. Dubaniewicz, A. Dubaniewicz (Gdansk, Wejherowo, Poland)
|  |
Decreased percentage of CD4+CD25+TGF-β+ cells and CD4+TGF-β+ cells in sarcoidosis
A. Barczyk, E. Sozanska, R. Wiaderkiewicz, M. Jarzab, M. Kaminski, W. Pierzchala (Katowice, Gliwice, Poland)
| |
Polymorphisms of the vitamin D receptor(VDR) gene, collagen type I alpha 1(COLIA1) gene in Polish sarcoidosis patients
E. Puscinska, A. Norek, D. Chmielewski, A. Goljan-Geremek, A. Rudnicka, J. Chorostowska-Wynimko, A. Skoczylas, M. Bednarek, A. Sobczynska-Tomaszewska, J. Bal, D. Gorecka (Warsaw, Poland)
| |
Comparative biochemical and cytological activity markers according to the radiographic pattern in patients with newly diagnosed sarcoidosis
L. I. Cervis, C. Teleaga, E. Crisan, R. Ulmeanu, M. Alexe, P. Grigore (Bucharest, Romania)
| |
The role of CRP as the activity marker during the course of sarcoidosis
J. Videnovic-Ivanov, V. Vucinic, S. Filipovic, V. Zugic, J. Stojsic (Belgrade, Serbia And Montenegro)
| |
Induced sputum TNF-α level as possible prognostic factor in sarcoidosis
H. Baradzina, I. Kotovich, A. Tahanovich (Minsk, Belarus)
| |
Study of angiotensin-converting enzyme, serum amyloid A, soluble interleukin-2 receptor, lysozyme and KL-6 in serum as diagnostic markers in pulmonary sarcoidosis
T. Kadowaki, H. Hamada, N. Hamaguchi, K. Sakai, R. Ito, J. Higaki (Toon, Ehime, Japan)
| |
Sarcoidosis – an initial radiological and clinical presentation in various ethnic groups
K. Nandakumar, P. Iles (Birmingham, United Kingdom)
| |
Multiple endobronchial nodules due to sarcoidosis
C. Ones, D. Marasli, A. Soyhan, A. Eren, A. Hazar (Istanbul, Turkey)
| |
Characteristic of sarcoidosis by gender
J. Videnovic-Ivanov, S. Filipovic, V. Vucinic, V. Zugic (Belgrade, Serbia And Montenegro)
| |
Hilar and mediastinal lymphadenopathy as a leading symptom of sarcoidosis
J. Stojsic, V. Vucinic-Mihailovic, J. Videnovic-Ivanov, S. Filipovic, J. Radojicic (Belgrade, Serbia And Montenegro)
| |
Lung function and haematological changes in patients with sarcoidosis
D. Korzybski, M. Czystowska, E. Puscinska, A. Goljan-Geremek, D. Gorecka (Warsaw, Poland)
| |
The pattern of disease and diagnostic yields in a cohort of patients with sarcoidosis in a regional centre
M. Uzbeck, R. Baggott, I. Saleem, R. Rutherford, J. J. Gilmartin (Galway, Ireland)
| |
BALF cells and pulmonary function in different radiographic stages of newly diagnosed sarcoidosis
E. Danila, L. Jurgauskiene, R. Nargela, V. Svedas, R. Malickaite, R. Balciuviene, B. Satkauskas (Vilnius, Lithuania)
| |
Vascular dysfunction in patients with pulmonary sarcoidosis
A. Rapti, I. Nikolopoulos, C. Papamichail, A. Paridou, A. Kyrkou, E. Gialafos, C. Triantafyllidis, O. Anagnostopoulou, C. Kostopoulos (Athens, Greece)
| |
Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with sarcoidosis – test of a new approach
E. I. Shmelev, A. S. Zayceva, I. V. Sivokozov (Moscow, Russian Federation)
| |
Fatigue in sarcoidosis; comparing American and Dutch patients
G. Jonker, M. Elfferich, E. Lower, R. Baughman, M. Drent, J. De Vries (Eindhoven, Maastricht, Tilburg, Netherlands; Cincinnati, United States Of America)
| |
Sex-specific phenotypes in the newly diagnosed sarcoidosis
L. I. Cervis, C. Teleaga, D. Ionita, R. Nemes, N. Bisca, E. Crisan, R. Ulmeanu, M. Alexe, P. Grigore, A. Serbescu (Bucharest, Romania)
| |
High-doses glucocorticosteroid treatment in sarcoidosis patients
B. Serge, K. Elena, F. Tatiana, B. Alexander, G. Lidia (Moscow, Russian Federation)
| |